Co-pathologies play an important role in the expression of the Alzheimer’s disease clinical
phenotype and may influence treatment efficacy. Early-onset Alzheimer’s disease, defined as …

The expression levels of three commonly used housekeeping genes, EF1-α, RPS20 and
Beta-Actin, were examined in seven different tissues and leucocytes from non-stimulated …

Clarifying the relationships between neuropsychiatric symptoms and Alzheimer’s disease (AD)-related
pathology may open avenues for effective treatments. Here, we investigate the …

The clinical spectrum of Alzheimer’s disease (AD) extends well beyond the classic amnestic–predominant
syndrome. The previous studies have suggested differential neurofibrillary …

Introduction Sleep-wake disturbances are a common and early feature in Alzheimer's
disease (AD). The impact of early tau pathology in wake-promoting neurons (WPNs) remains …

Disturbances of the sleep/wake cycle in Alzheimer's disease (AD) are common, frequently
precede cognitive decline, and tend to worsen with disease progression. Sleep is critical to …

The R47H variant of triggering receptor expressed on myeloid cells 2 (TREM2) increases
the risk of Alzheimer's disease (AD). To investigate potential mechanisms, we analyzed …

Importance Sleep disturbance is common among patients with neurodegenerative diseases.
Examining the subcortical neuronal correlates of sleep disturbances is important to …

Sleep and wakefulness control in the mammalian brain requires the coordination of various
discrete interconnected neurons. According to the most conventional sleep model, wake-…

The brainstem nuclei of the reticular formation (RF) are critical for regulating homeostasis,
behavior, and cognition. RF degenerates in tauopathies including Alzheimer disease (AD), …